Regulatory & Reimbursement Implications of FDA Breakthrough Device Designation

Time: 1:30 pm
day: Day Two

Details:

• Overview of the FDA Breakthrough Devices program and eligibility criteria
• Discussion on what Breakthrough Device designation might mean for digital therapeutics companies
• Exploring emerging CMS reimbursement opportunities for Breakthrough devices

Speakers: